Mounjaro 7.5 mg KwikPen 2.4 ml

Mounjaro 7.5 mg KwikPen Overview:

Mounjaro 7.5 mg KwikPen is an anti-diabetic medication used in combination with diet and exercise to improve blood sugar control in adults with Type 2 diabetes mellitus. It is prescribed when lifestyle changes and previous treatment with oral anti diabetic medications do not adequately control blood glucose levels.

By stimulating insulin production and improving insulin sensitivity, Mounjaro 7.5 mg KwikPen helps lower blood sugar levels and reduce the risk of diabetes related complications.

Composition:

Each 0.6 ml contains 7.5 mg of Tirzepatide, Dibasic Sodium Phosphate Heptahydrate (0.80 mg), Sodium Chloride (1.05 mg), Glycerin (4.8 mg), Benzyl Alcohol (5.4 mg), Phenol (1.08 mg), Hydrochloric Acid Solution (q.s.), Sodium Hydroxide Solution (q.s.), Water for Injection (q.s. to 0.6 ml)

Uses & Benefits of Mounjaro 7.5 mg KwikPen:

Mounjaro 7.5 mg KwikPen is prescribed for the following conditions:

• Type 2 Diabetes Mellitus – Mounjaro 7.5 mg KwikPen supports blood sugar management in adults with Type 2 diabetes by encouraging the body to produce more insulin and utilize it more efficiently, thereby helping to maintain healthy glucose levels.

How Mounjaro 7.5 mg KwikPen Works:

Mounjaro 7.5 mg KwikPen contains Tirzepatide, an active compound that mimics the activity of two naturally occurring incretin hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). These hormones are released from the intestines following a meal and play a central role in regulating blood sugar. Together, GIP and GLP-1 stimulate the pancreas to release insulin in response to elevated blood sugar and suppress glucagon, a hormone responsible for prompting the liver to release glucose into the bloodstream. Tirzepatide also slows the digestive process, helping to prevent sudden post-meal blood sugar spikes. Through this dual hormonal mechanism, Tirzepatide enhances insulin response and supports effective long-term management of Type 2 diabetes.

Dosage of Mounjaro 7.5 mg KwikPen:

• Usage Direction

Mounjaro 7.5 mg KwikPen is intended for subcutaneous use only and should be administered once a week by a healthcare professional. It should be injected into areas of the body with a layer of fat just beneath the skin, such as the upper thigh, upper arm, or abdomen. To reduce the risk of skin irritation, the injection site should be rotated each week. Do not attempt to self-administer this medication. Your doctor will determine the appropriate dosage based on your medical condition and how you respond to treatment. Do not stop or alter the dose of Mounjaro 7.5 mg KwikPen without consulting your doctor, as this may prevent you from achieving the desired result.

• Missed Dose

In case you miss or forget to take your Mounjaro 7.5 mg KwikPen, and it has been 4 days (96 hours) or less, take the missed dose as soon as possible. However, if more than 4 days have passed, omit the missed dose and continue with your usual weekly dosing schedule. Never take double doses at the same time to make up for the missed one.

• Overdose

If you accidentally use Mounjaro 7.5 mg KwikPen more than your prescribed dose, you should talk to your doctor immediately. Too much of this medicine may lead to low blood sugar (hypoglycaemia).

Contraindications of Mounjaro 7.5 mg KwikPen:

Do not use Mounjaro 7.5 mg KwikPen if you are allergic to tirzepatide or any of the other ingredients of this medicine. This medication should also be avoided if you or any of your family members have ever had a rare type of thyroid cancer called medullary thyroid carcinoma (MTC), or if you have a genetic condition known as Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Precautions & Warnings of Mounjaro 7.5 mg KwikPen:

Before starting treatment with Mounjaro 7.5 mg KwikPen, inform your doctor if you have any digestive conditions, such as gastroparesis or delayed stomach emptying, as this medication can further slow digestion and potentially worsen symptoms. You should also let your doctor know if you have a history of pancreatitis, diabetic retinopathy, or macular edema, because rapid improvements in blood sugar control might temporarily make these conditions worse. Additionally, if you are taking other diabetes medications such as sulphonylureas or insulin, or if you are using oral contraceptives, it is important to consult your doctor before starting Mounjaro. In these cases, your doctor may need to adjust the dosage of your diabetes treatment or birth control to maintain both safety and effectiveness.

Side Effects of Mounjaro 7.5 mg KwikPen:

Mounjaro 7.5 mg KwikPen can cause some side effects, most of which are mild and go away as your body becomes used to the medicine. However, if these symptoms continue, it is important to consult your doctor. Common side effects include nausea, diarrhea, constipation, decreased appetite, vomiting or upset stomach, etc. Stomach pain, swelling of the hands, feet, ankles, face, lips, mouth or throat, difficulty in breathing, dizziness or fainting, irregular heartbeat, low blood sugar are some serious side effects which must require medical attention.

Safety Related Concerns of Mounjaro 7.5 mg KwikPen:

• Pregnancy

If you are pregnant or planning to become pregnant, talk to your doctor to determine if Mounjaro 7.5 mg KwikPen is safe for you, as it may affect the developing fetus during pregnancy.

• Breastfeeding

Breastfeeding mothers are advised to avoid Mounjaro 7.5 mg KwikPen as it may pass through breast milk and can cause side effects in breastfed babies. Therefore, while breastfeeding, consult your doctor before taking Mounjaro 7.5 mg KwikPen.

• Alcohol

Avoid consuming alcohol while taking Mounjaro 7.5 mg KwikPen, as this medicine may irritate the stomach lining and may cause dizziness or lightheadedness.

• Food or Interactions with Other Medicines

While using Mounjaro 7.5 mg KwikPen, it is advisable to avoid carbohydrate-rich foods, especially those high in sugar, as well as high-fat foods, as they can interfere with blood sugar control and worsen gastrointestinal side effects like nausea or indigestion. Also, if you are allergic to any food, it is recommended to avoid those specific foods while taking Mounjaro.

Consult your doctor if you are taking any herbal products or medicines, any supplements or other medicines while taking Mounjaro 7.5 mg KwikPen. As always, please consult your doctor or healthcare provider about your specific dietary needs while on Mounjaro 7.5 mg KwikPen.

• Driving & Using Machinery

If you experience side effects such as dizziness or blurred vision, you should avoid driving or operating machinery while taking Mounjaro 7.5 mg KwikPen.

Storage of Mounjaro 7.5 mg KwikPen:

• Store refrigerated at 2°C to 8°C in original carton to protect from light. Do not freeze.
• Mounjaro 7.5 mg KwikPen can be stored at room temperature up to 30°C for up to 30 days.
• The pen must be discarded 30 days after first use.
• For more information on storage, please refer to the package insert.
• Keep out of reach of children.

Other Notes:

• Maintain a healthy diet, reducing your intake of sugary and carbohydrate rich foods may help improve your condition.
• Monitor your blood sugar regularly,
• Rotate injection sites with each weekly dose to avoid skin irritation or tissue damage.
• Consult your doctor before taking any other antidiabetic medication to avoid interactions or increased risk of hypoglycemia.
• Always carry glucose or sugary foods with you in case of low blood sugar (hypoglycemia).
• Do not use the injection if the packaging is torn, damaged, or shows signs of tampering.
• Never share your injection pen or needle as it can lead to cross-contamination and serious infections.

Related Blood Glucose Monitoring Systems:

To manage diabetes at home, discover our simple, reliable home-use Blood Glucose Monitoring systems with Test Strips. Check Out

Frequently Asked Questions (FAQs)-

Q. What is Mounjaro 7.5 mg KwikPen used for?

A: Mounjaro 7.5 mg KwikPen is used to improve blood sugar control in adults with Type 2 diabetes mellitus, especially when diet, exercise, and oral anti diabetic medications are not enough.

Q. How is Mounjaro 7.5 mg KwikPen administered?

A: Mounjaro 7.5 mg KwikPen is given once weekly through a subcutaneous injection (under the skin) by a qualified healthcare practitioner. It should be injected into the upper thigh, upper arm, or abdomen, and the injection site should be rotated each week to reduce irritation. Self-injection is not recommended.

Q. When should I take Mounjaro 7.5 mg KwikPen?

A: Mounjaro 7.5 mg KwikPen should be administered once every week on the same day each week.

Q. Are there any common side effects of Mounjaro 7.5 mg KwikPen?

A: Nausea, vomiting, diarrhea, constipation, and decreased appetite are the common side effects of Mounjaro 7.5 mg KwikPen and are often mild and improve with time.

Q. Can Mounjaro 7.5 mg KwikPen cause severe drop in blood sugar levels?

A: Yes, Mounjaro 7.5 mg KwikPen can cause sudden and significantly low blood sugar (hypoglycemia), particularly when used in combination with other diabetes medications such as insulin or sulfonylureas. It is important to monitor your blood sugar regularly and carry glucose or sugary snacks in case of hypoglycemia.

Reference:

1. MOUNJARO® KwikPen® pre-filled pen. Consumer Medicine Information (CMI) summary. Last Update: June 2025. Accessed on: 21.08. 2025. Click Here

2. INSTRUCTIONS FOR USE PrMOUNJARO® KwikPen® tirzepatide injection multi-dose prefilled pen for subcutaneous use. Last Update: July 2025. Accessed on: 21.08. 2025. Click Here

3. Mounjaro KwikPen 2.5mg solution for injection in pre-filled pen. Last Update: 9th July 2025. Accessed on: 21.08. 2025. Click Here